Urine test for kidney cancer a step closer to development
A team of researchers at Washington University School of Medicine in St. Louis has identified a pair of proteins excreted in the urine that could lead to earlier and more accurate diagnosis of kidney cancer. The research is the first to identify proteins in urine that appear to accurately reveal the presence of about 90 percent of all kidney cancers.
Loeb Teaching Fellows announced
Michael M. Awad, MD, Joan Rosenbaum, MD, and Gladys Tse, MD, have been chosen for the 2010-12 Carol B. and Jerome T. Loeb Teaching Fellowships at the School of Medicine.
$3.8 million NIH grant funds WUSTL brain imaging center
Researchers at Washington University School of Medicine in St. Louis have received a five-year, $3.8 million grant from the National Institute of Neurological Disorders and Stroke to renew a center that helps researchers collect and use data on the brain and central nervous system.
Obituary: I. Jerome Flance, 98
I Jerome Flance, an emeritus clinical professor of medicine at the Washington University School of Medicine who spearheaded the University’s development of the Forest Park Southeast neighborhood, died Friday (April 2, 2010) of infirmities of age at Barnes-Jewish Hospital. He was 98 and lived in Creve Coeur.
Healthy environment key to combating obesity in children
Parents, schools and communities need to be involved in combating the epidemic of childhood obesity, Debra Haire-Joshu, PhD, says.
Kharasch named vice chancellor for research
Evan D. Kharasch, MD, PhD, the Russell D. and Mary B. Shelden Professor of Anesthesiology and professor of biochemistry and molecular biophysics, has been appointed vice chancellor for research at Washington University in St. Louis, effective April 5. He had served as interim vice chancellor since July 2009. As the chief officer responsible for the university’s research mission, he will oversee an enterprise that generates more than $500 million annually for sponsored research from a wide array of funding sources.
Drug reduces risk of prostate cancer diagnosis in high-risk men
A drug already prescribed to shrink benign, enlarged prostates has been shown to reduce the risk of a prostate cancer diagnosis by 23 percent in men with an increased risk of the disease, a large international trial has found. Results are reported April 1 in the New England Journal of Medicine.
Tweet: Scientists decode songbird’s genome
Nearly all animals make sounds instinctively, but baby songbirds learn to sing in virtually the same way human infants learn to speak: by imitating a parent. Now, an international team of scientists, led by the School of Medicine, has decoded the genome of a songbird — the Australian zebra finch — to reveal intriguing clues about the genetic basis and evolution of vocal learning.
The Department of Pediatrics celebrates its first 100 years
There will be a year of festivities as the Department of Pediatrics celebrates its centennial April 1 to honor the milestones. Currently ranked eighth in the nation by U.S. News & World Report, the Department of Pediatrics has become a world leader in pediatric patient care, teaching and research with its many groundbreaking discoveries and for its excellence in all divisions.
Scans of brain networks may help predict injury’s effects
Clinicians may be able to better predict the effects of strokes and other brain injuries by adapting a scanning approach originally developed for the study of brain organization, neurologists at Washington University School of Medicine in St. Louis have found.
View More Stories